CliffBio
small molecule

CEFTAROLINE FOSAMIL

CEFTAROLINE FOSAMIL

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFTAROLINE FOSAMIL
Active ingredientCEFTAROLINE FOSAMIL
Strength600MG/VIAL
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalSeptember 2021
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.